in vitro News and Research

RSS
Kolltan announces presentation of data from KTN0158 preclinical study in mast cell tumors at ESMO 2015

Kolltan announces presentation of data from KTN0158 preclinical study in mast cell tumors at ESMO 2015

Standard clomiphene treatment better than proposed alternative for unexplained fertility

Standard clomiphene treatment better than proposed alternative for unexplained fertility

New study on deep-diving whales may help researchers create synthetic blood for human trauma patients

New study on deep-diving whales may help researchers create synthetic blood for human trauma patients

HIV cure research may shift from single-therapy development model to combination therapy trials

HIV cure research may shift from single-therapy development model to combination therapy trials

EKF’s new Altair 240 revealed to UK audience at IBMS 2015

EKF’s new Altair 240 revealed to UK audience at IBMS 2015

Protein-coding gene identified as tumor suppressor for acute myeloid leukemia

Protein-coding gene identified as tumor suppressor for acute myeloid leukemia

Pabetalone (RVX-208) to be tested in proof-of-concept pilot study in complement mediated diseases

Pabetalone (RVX-208) to be tested in proof-of-concept pilot study in complement mediated diseases

Novel mechanism may help explain the virulence of 1918 'Spanish' flu

Novel mechanism may help explain the virulence of 1918 'Spanish' flu

Paxman unveils commitment to ‘chase zero hair loss during chemotherapy’ at 2015 European Cancer Congress

Paxman unveils commitment to ‘chase zero hair loss during chemotherapy’ at 2015 European Cancer Congress

Study demonstrates potential of FCPCs as new source for cartilage regeneration

Study demonstrates potential of FCPCs as new source for cartilage regeneration

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

VolitionRx's NuQ blood test receives CE Mark approval for detection of colorectal cancer

VolitionRx's NuQ blood test receives CE Mark approval for detection of colorectal cancer

Common Alzheimer's disease drug increases bone density, reduces fracture risks

Common Alzheimer's disease drug increases bone density, reduces fracture risks

New Locilex microbiology data presented at ICAAC/ICC 2015 scientific conference

New Locilex microbiology data presented at ICAAC/ICC 2015 scientific conference

Promising new innovations in drug development, health monitoring may improve drug safety in the future

Promising new innovations in drug development, health monitoring may improve drug safety in the future

Combination of TXA709 and cefdinir demonstrates synergistic antibacterial activity against MRSA

Combination of TXA709 and cefdinir demonstrates synergistic antibacterial activity against MRSA

Researchers identify new epigenetic markers for colorectal cancer

Researchers identify new epigenetic markers for colorectal cancer

Scientists discover mechanism that could lead to new treatment for allergies

Scientists discover mechanism that could lead to new treatment for allergies

New study reveals pivotal role of miR-506 biomarker in gastric cancer

New study reveals pivotal role of miR-506 biomarker in gastric cancer

Penn researchers identify viral products that trigger immune response against RSV infection

Penn researchers identify viral products that trigger immune response against RSV infection

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.